Exciting research out of the University of Cincinnati was revealed this week in which transplant rejection was halted and reversed by use of a cancer drug. It was reported in the Washington Post this weekend and the researchers speculated that the role of plasma cells and the antibodies they produce have perhaps been underestimated. The side effects of the use of the drug were described as manageable. The Kidney Group is encouraged by this avenue of research and we in fact have patients who are currently on the list for a kidney transplant with the hospital that generated the research. Your physician here at The Kidney Group can answer any questions about the study you may have. Click the title of this post for a link to the full story.
